Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Gynecologic 1Genitourinary 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 11Anemia, Refractory, with Excess of Blasts 11Neoplasms 9Myelodysplastic Syndromes 8Venous Thromboembolism 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Anemia, Aplastic 5Myeloproliferative Disorders 4Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Fanconi Anemia 4Anemia 4Pulmonary Embolism 3Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Multiple Myeloma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hodgkin Disease 3Congenital Bone Marrow Failure Syndromes 3Burkitt Lymphoma 3Blast Crisis 3Anemia, Sickle Cell 3Venous Thrombosis 2Recurrence 2Neutropenia 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphedema × Classical hematology × 30 days × Clear all
NCT07612865 2026-05-29

People's Hospital of Xinjiang Uygur Autonomous Region

People's Hospital of Xinjiang Uygur Autonomous Region

Phase NA Completed
160 enrolled
Classical hematologyGynecologic

Uterine Cervical Neoplasms, Lymphedema, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡